NFATC1 and non-small cell lung carcinoma: To validate our model prediction that NFATc functions as a PSF for the hybrid E/M phenotype, we knocked down NFATc1 using siRNAs in NSCLC H1975 cells with a stable hybrid E/M phenotype.